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Objective: To evaluate anatomical and functional outcomes after silicone oil extraction in patients with retinal
detachment and proliferative vitreoretinopathy in an eye care referral center in Joinville, SC, southern Brazil.
Methods: Retrospective, noncomparative study of patients with retinal detachment and posterior proliferative
vitreoretinopathy followed up after silicone oil removal. Prophylactic 360-degree peripheral laser photocoagulation
was performed one to three months before silicone oil extraction. Patients with cataract underwent a combined
clear corneal phacoemulsification with intraocular lens implantation in the same procedure. Anatomical outcomes
were related to the duration of silicone oil tamponade and the surgical procedure performed. Functional outcomes
were divided into three categories (stability, worsening, or improvement) according to visual acuity variation before
the surgery and at the last follow-up visit.
Results: Fifty-three patients were followed up for a mean period of 1,262 days.
Fourteen eyes (26.4%) underwent cataract surgery combined with silicone oil extraction. Forty-eight eyes (90.5%)
had attached retina at the last follow-up examination. Time of intraocular tamponade and association of
phacoemulsification with silicone oil extraction were not considered as risk factors for retinal redetachment.
Twenty-three cases (43.4%) showed visual acuity improvement, whereas 11 cases (20.8%) were stable and 19 cases
(35.8%) showed visual acuity worsening. Five patients with attached retina had unexplained optic disc atrophy.
Conclusion: Most patients had good anatomical and visual outcomes after silicone oil extraction. Prophylactic
360-degree laser retinopexy may have led to favorable outcomes. Benefits of silicone oil extraction and the
associated risks of complications due to a new surgical procedure must be carefully evaluated before surgical indication.
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Proliferative vitreoretinopathy (PVR) is an important
complication of rhegmatogenous retinal detachment and
its treatment requires a long-acting endotamponade,
such as silicone oil, to reduce the rate of recurrent retinal
detachment [1,2].
To avoid long-term complications due to the presence of
silicone oil inside the eye, such as cataract, glaucoma and
ceratopathy, its removal is usually necessary. Nevertheless,* Correspondence: re_tavares@hotmail.com
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sequently retinal redetachment can occur. It is generally
associated with residual vitreoretinal traction at the vitre-
ous base [3,4]; some other factors may also contribute to
unfavorable outcomes, like intra and postoperative inflam-
mation, intraoperative bleeding, retinal pigment epithelium
exposure, retinectomy and extended duration of the surgi-
cal procedure.
As suggested by some authors, a prophylactic 360-
degree laser retinopexy prior to silicone oil extraction
may help to reduce retinal redetachment rates [5-7].
Additionally, in spite of a permanent attached retina,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Inicial operative procedure: rhegmatogenous retinal
detachment and grade C posterior proliferative vitreoretinopathy
(A) and postoperative result after silicone oil infusion (B).
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silicone oil extraction [1,3-7].
The objective of the present study is to evaluate ana-
tomical and functional outcomes after silicone oil removal
in patients with retinal detachment and proliferative vi-
treoretinopathy in an eye care referral center in Joinville,
SC, southern Brazil.
Methods
A retrospective, noncomparative clinical series of pa-
tients with rhegmatogenous retinal detachment and pos-
terior PVR grade A, B, C1, C2, C3, D1 and D2 examined
after silicone oil extraction. Surgical interventions were
performed between January 1997 and February 2013.
The patients were examined and operated on by the
same surgeon (MJN).
The initial operative procedure consisted of 20-gauge
pars plana vitrectomy, 360-degree scleral buckle, laser
endophotocoagulation surrounding retinal tears, and in-
fusion of 5000-centistoke silicone oil (Ophthalmos®, São
Paulo, SP) into the vitreous cavity (Figure 1). Prophylac-
tic 360-degree peripheral laser photocoagulation was
performed one to three months before silicone oil ex-
traction. Laser spots were delivered to the scleral buckle
area in two or three rows via slit lamp.
Silicone oil was extracted between 6 weeks and
12 months after the initial procedure through a standard
two-port pars plana surgery. If there was cataract, a
combined clear corneal incision phacoemulsification and
intraocular lens (IOL) implantation was performed. Dur-
ing follow-up period, logMAR best-corrected visual acuity
(BCVA), intraocular pressure (IOP), slit-lamp biomi-
croscopy, indirect and slit-lamp ophthalmoscopy were
registered.
Functional outcomes were divided into three categor-
ies. Patients who had a final logMAR BCVA showing a
0.1-variation compared to the baseline BCVA were con-
sidered stabilized; a visual acuity variation was significant
if the difference between baseline and final BCVA was
0.2 logMAR. A severe visual worsening was registered if
there was a BCVA reduction of 0.3 logMAR or more.
Statistical analysis was performed using STATA version
12.0 (Texas USA). Categorical variables were expressed by
frequencies and percentages and the continuous variables
were expressed through means and standard deviation,
with a confidence interval of 95%. The Student’s t-test was
used to evaluate relation between mean period of silicone
oil tamponade and retinal detachment as well as to com-
pare visual acuity means before and after silicone oil
removal. Pearson’s Chi-square test, or the Fischer
exact test, was used to assess causality of using the
combined procedure (silicone oil removal, phacoemulsifi-
cation and IOL implantation) with retinal re-detachment
cases, and also correlate it with final visual acuity.Significance level of 5% was accepted to reject the
null hypothesis.
The informed consent to participate in the study was
obtained from each patient. Hospital Municipal São José’s
ethical committee, Joinville – Santa Catarina, Brazil, ap-
proved the research according to the project number:
240.558.
Results
Fifty-three eyes of 53 patients were included; thirty-three
(62%) patients were male; mean age was 52.7 years
(range 16–79 years). According to PVR classification,
3.8% (2/53) of the patients were grade A PVR; 5.6%
(3/53) grade B PVR; 32.1% (17/53) grade C1 PVR;
18.9% (10/53) grade C2 PVR; 5.6% (3/53) grade C3
PVR; 1.9% (1/53) grade D1 PVR and 1.9% (1/53)
grade D2 PVR; 30.2% (16/53) of the patients had no
classifying register. Follow-up varied from 256 days to
4,421 days (mean 1,262 + −944 days). The median time
Tavares et al. International Journal of Retina and Vitreous  (2015) 1:2 Page 3 of 5of silicone oil extraction was 196 days after its place-
ment. The mean intraocular pressure was 15.6 + −7.4
before and 14.8 + −6.2 after silicone oil removal. Pha-
coemulsification with IOL implantation was combined
with silicone oil removal in 14 eyes (26.4%) (Figure 2A).
Forty-eight (90.5%) patients had attached retina at the
last follow-up visit (Figure 2B). The mean period of sili-
cone oil duration in the vitreous cavity was 228 + −152
and 275 + −265 days in cases with and without redetach-
ment, respectively. There was no association between
duration of intraocular silicone oil and risk for retinal
redetachment (p = 0.6997). The rate of retinal redetach-
ment in patients submitted to phacoemulsification com-
bined with silicone oil extraction was 21.4% (Figure 2C),
which represented 60% of all the redetachment cases
(Figure 2D), but not statiscally significant (p = 0.0735).
Twenty-three patients (43.4%) showed BCVA improve-
ment, eleven patients (20.8%) were stabilized and 19 pa-
tients (35.8%) had a BVCA worsening. Mean preoperative
and postoperative values of BCVA were 0.95 logMAR
(Snellen = 20/160) and 1.01 logMAR (Snellen = 20/200)
respectively (Figure 3). Severe visual worsening was obser-
ved in 15 patients (28.3%), of whom five had unexplained
optic disc atrophy.
Combined phacoemulsification with intraocular lens
implant and removal of silicone oil did not influence the
final visual acuity when compared to the isolated extraction
of silicone oil (p = 0.426). In addition, BCVA worseningFigure 2 Anatomical results after silicone oil removal and comparison bcould not be directly associated with silicone oil removal
(p = 0.6598).
Discussion
Several factors may be related to anatomic and functional
outcomes after silicone oil extraction in PVR cases. In this
study, the relation between duration of silicone oil tam-
ponade and incidence of retinal redetachment was not
established. In the literature, while some authors did not
consider the timing of silicone oil removal as a risk factor
for anatomic success rate [4,8,9], others observed that
shorter tamponade duration had lower attachment rate
than longer tamponade duration [10,11].
The association of encircling buckle and peripheral
laser photocoagulation prior to silicone oil extraction
has been previously reported as safe and advantageous
[9,12-15]. A 360-degrees laser performed previously to
surgery may improve peripheral chorioretinal adhesion
and avoid retinal redetachment in spite of residual vitre-
ous base traction [3,7,16].
Compared to other studies (Table 1), the present report
showed a low redetachment rate (9.5%) after silicone oil
extraction. This may be due to improved surgical manage-
ment of complicated retinal detachments in the last years,
especially adequate vitreous removal with the use of wide-
field viewing systems [7,12].
A combined surgery, with longer duration and more
intense inflammation, may predispose to postoperativeetween single and combined procedure with phacoemulsification.
Figure 3 Comparison of BCVA between preoperative examination and last follow-up assessment.
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showed a higher rate of retinal detachment recurrence
in eyes submitted to silicone oil extraction associated
with cataract surgery than eyes that had only silicone oil
removal (21.4% vs. 5.1%); however, this result was not
statistically significant (p = 0.0735).
Functional outcomes were not fully correlated with
anatomical outcomes. To date, there is no definite ex-
planation for vision loss or optic atrophy after silicone
oil extraction. A long-term and close contact of silicone
oil with the retina may cause toxicity; abnormal potas-
sium exchanges and dysfunction of central Müller cellsTable 1 Previous studies showing rate of retinal
redetachment after silicone oil extraction and number of
treated eyes
% Redetach Treat eyes
Bassat et al. [22] (2000) 9.3 32
Flaxel et al. [23] (2000) 34 62
Scholda et al. [11] (2000) 16.1 112
Assi et al. [24] (2001) 20.2 74
Falkner et al. [1] (2001) 16.5 103
Jonas et al. [4] (2001) 27.6 185
Jiang et al. [25] (2002) 20.2 168
Unlu et al. [26] (2004) 9.5 21
Scott et al. [27] (2005) 21 57
Soheilian et al. [28] (2006) 28 82
Lam et al. [8] (2008) 18.4 147
Jain et al. [15] (2010) 11.6 300
Nagpal et al. [9] (2012) 12.7 370may also explain a shallow foveal depression and vision
loss [13-15].
Besides surgical intervention, new types of treatment
for PVR are being tested in clinical trials. Several studies
have been performed, including use of many drugs, such
as daunorubicin, corticosteroids, 5-fluorouracil, heparin
and colchicine [17-21]. Nonetheless, PVR is still a chal-
lenge and continues to be the most common cause of
surgical failure following retinal detachment surgery.
The main limitation of the present study is its retrospect-
ive and noncomparative design. Because of the patients’
records were not standardized, some complementary data,
such as analysis of macular optic coherence tomography
and visual field, could not be included. The size of the sam-
ple may also have influenced the results; a higher number
of treated eyes could permit other comparisons and dem-
onstrate significant differences between the outcomes.
As described in other reports, this study shows how
critical is the dilemma concerning treatment of complex
rhegmatogenous retinal detachment. Silicone oil removal
provided favorable anatomical and functional results in
the majority of the operated eyes and prophylactic per-
ipheral laser retinopexy may have contributed to this.
However, some eyes developed unexplained vision loss
after silicone oil extraction and there was also a trend to
retinal redetachment when silicone oil removal was
combined with phacoemulsification and intraocular lens
placement.
Conclusion
In summary, low detachment rate may be due to improved
surgical management of complicated retinal detachments
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must be aware of adverse results associated with silicone
oil removal. Benefits of silicone oil extraction must be
outweighed against its extended duration in the eye and
the possibility of complications after a new surgical
procedure.
Abbreviations
PVR: Proliferative vitreoretinopathy; IOL: Intraocular lens; BCVA: Best-corrected
visual acuity.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RLPT: conception and design, acquisition, analysis and interpretation of data;
involved in drafting the manuscript and its revising. MJN: conception, design,
contributed in drafting, responsible for critical revision and has given final
approval of the version to be published. FAJN: design, acquisition and
interpretation of data. FJN: conception, design and revising. CACO: statistical
analysis and interpretation of data. All authors read and approved the final
manuscript.
Author details
1Hospital de Olhos de Londrina (HOFTALON), Londrina, PR - Brazil, Rua Belo
Horizonte 1330, ap 1401, Londrina, PR CEP 86020-060, Brazil. 2Hospital de
Olhos Sadalla, Universidade da Região de Joinville, Amin Ghanem, Joinville,
SC, Brazil. 3Universidade de Alfenas (UNIFENAS), Alfenas, MG, Brazil.
Received: 4 December 2014 Accepted: 12 February 2015
References
1. Falkner CI, Binder S, Kruger A. Outcome after silicone oil removal.
Br J Ophthalmol. 2001;85(11):1324–7.
2. Ryan SJ. The pathophysiology of proliferative vitreoretinopathy in its
management. Am J Ophthalmol. 1985;100(1):188–93.
3. Jain P, Napgal M, Videkar R, Napgal K, Patil A: Evaluation of possible risk
factors for retinal re-detachment after silicone oil removal. In: AIOC,
Retina/Vitreous session – IV. 2010:655–6.
4. Jonas JB, Knor HL, Rank RM, Budde WM. Retinal redetachment after removal
of intraocular silicone oil tamponade. Br J Ophthalmol. 2001;85(10):1203–7.
5. Hutton LW, Azen PS, Blumenkranz SM, Lai MY, McCuen BW, Han DP, et al.
The effects of silicone oil removal. Silicone study report 6. Arch Ophthalmol.
1994;112(6):778–85.
6. Steel DH, Weir P, James CR. Silicone assisted, argon laser confinement of
recurrent proliferative vitreoretinopathy relates retinal detachment: a
technique to allow silicone oil removal in problem eyes. Br J Ophthalmol.
1997;81(9):765–70.
7. Tufail A, Schwartz SD, Gregor ZJ: Prophylactic argon laser retinopexy prior
to removal of silicone oil: a pilot study. Eye (Lond).1997;11 (Pt 3):328–30.
8. Lam RF, Cheung BTO, Yuen CYF, Wong D, Lam DSC, Lai WW. Retinal
redetachment after silicone oil removal in proliferative vitreoretinopathy: a
prognostic factor analysis. Am J Ophthalmol. 2008;145(3):527–33.
9. Nagpal MP, Videkar RP, Nagpal KM. Factors having implications on
reretinal detachments after silicone oil removal. Indian J Ophthalmol.
2012;60(6):517–20.
10. Tan HS, Dell’omo R, Mura M. Silicone oil removal after rhegmatogenous
retinal detachment: comparing techniques. Eye (Lond). 2012;26(3):444–7.
11. Scholda C, Egger S, Lakits A, Walch K, von Eckardstein E, Biowski R.
Retinal detachment after silicone oil tamponade. Acta Ophtalmol Scand.
2000;78(2):182–6.
12. Laidlaw DA, Karina N, Bunce C, Aylward GW, Gregor ZJ. Is prophylactic
360-degree laser retinopexy protective? risk factors for retinal redetachment
after removal of silicone oil. Ophthalmology. 2002;109(1):53–8.
13. Cazabon S, Groenewald C, Pearce IA, Wong D. Visual loss following removal
of intraocular silicone oil. Br J Ophthalmol. 2005;89(7):799–802.
14. Williams PD, Fuller CG, Scott IU, Fuller DG, Flynn HW. Vision loss associates
with the use and removal of intraocular silicone oil. Clin Ophthalmol.
2008;2(4):955–9.15. Jain N, McCuen 2nd BW, Mruthyunjaya P. Unanticipated vision loss after
pars plana vitrectomy. Surv Ophthalmol. 2012;57(2):91–104.
16. Avitabile T, Longo A, Lentini G, Reibaldi A. Retinal detachment after silicone
oil removal is prevented by 360 degrees laser treatment. Br J Ophthalmol.
2008;92:1479–82.
17. Sun JK, Arroyo JG. Adjunctive therapies for proliferative vitreoretinopathy.
Int Ophthalmol Clin. 2004;44(3):1–10.
18. Wiedemann P, Hilgers RD, Bauer P, Heimann K, Daunomycin Study Group.
Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy:
results of a multicenter clinical trial. Am J Ophthalmol. 1998;126(4):550–9.
19. Shinohara K, Tanaka M, Sakuma T, Kobayashi Y. Efficacy of daunorubicin
encapsulated in liposome for the treatment of proliferative
vitreoretinopathy. Ophthalmic Surg Lasers Imaging. 2003;34(4):299–305.
20. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, et al. Adjuvant
5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results
from a randomized, double-blind, controlled clinical trial. Ophthalmology.
2001;108(7):1179–83.
21. Wickham L, Bunce C, Wong D, McGurn D, Charteris DG. Randomized
controlled trial of combined 5-Fluorouracil and low-molecular-weight
heparin in the management of unselected rhegmatogenous retinal
detachments undergoing primary vitrectomy. Ophthalmology.
2007;114(4):698–704.
22. Bassat IB, Desatnik H, Alhalel A, Treister G, Moisseiev J. Reduced
rate of retinal detachment following silicone oil removal. Retina.
2000;20(6):597–603.
23. Flaxel CJ, Mitchell SM, Aylward GW. Visual outcome after silicone oil
removal and recurrent retinal detachment repair. Eye. 2000;14:834–8.
24. Assi A, Woodruff S, Gotzaridis E, Bunce C, Sullivan P. Combined
phacoemulsification and transpupillary drainage of silicone oil: results and
complications. Br J Ophthalmol. 2001;85(8):942–5.
25. Jiang F, Krause M, Ruprecht KW, Hille K: Management and results of
retinal detachment after silicone oil removal. Ophthalmologica.
2002 Sep-Oct;216(5):341–5.
26. Unlu N, Kocaoglan H, Acar MA, Sargin M, Aslan BS, Duman S. Outcome
of complex retinal detachment surgery after silicone oil removal.
Int Ophthalmol. 2004;25(1):33–6.
27. 27. Scott IU, Flynn Jr HW, Murray TG, Smiddy WE, Davis JL, Feuer WJ:
Outcomes of complex retinal detachment repair using 1000- vs
5000- centistoke silicone oil. Arch Ophthalmol. 2005 Apr;123(4):473–8.
28. Soheilian M, Mazareei M, Mohammadpour M, Rahmani B: Comparison of
silicon oil removal with various viscosities after complex retinal detachment
surgery. BMC Ophthalmol. 2006 May; 31;6:21.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
